Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior
Shuo Chen, Xi Chen, Tao Shan, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 1, pp. 100-110
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

miRNA-based biomarkers, therapies, and resistance in Cancer
Boxue He, Zhenyu Zhao, Qidong Cai, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 14, pp. 2628-2647
Open Access | Times Cited: 451
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
Divya Thomas, Prakash Radhakrishnan
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 340
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Qin Cheng, Gang Yang, Jinshou Yang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 294
The enhancement of glycolysis regulates pancreatic cancer metastasis
Jinshou Yang, Bo Ren, Gang Yang, et al.
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 2, pp. 305-321
Closed Access | Times Cited: 281
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 237
Formononetin: A Review of Its Anticancer Potentials and Mechanisms
Kai-Ching Tay, Loh Teng‐Hern Tan, Chim Kei Chan, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 235
Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics
Susi Zhu, Yeye Guo, Xu Zhang, et al.
Cancer Letters (2020) Vol. 503, pp. 240-248
Closed Access | Times Cited: 161
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
Mehrdad Hashemi, Motahare Sadat Ayat Mirdamadi, Yasmin Talebi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106568-106568
Open Access | Times Cited: 70
‘Reverse Warburg effect’ of cancer‑associated fibroblasts (Review)
Lin Liang, Wentao Li, Xin Li, et al.
International Journal of Oncology (2022) Vol. 60, Iss. 6
Open Access | Times Cited: 68
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 12
Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells
Christos Sazeides, Anne Le
Advances in experimental medicine and biology (2018), pp. 149-165
Closed Access | Times Cited: 67
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
Rebecca Raue, Ann-Christin Frank, Shahzad N. Syed, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2210-2210
Open Access | Times Cited: 43
Cancer-associated fibroblast-derived exosome microRNA-21 promotes angiogenesis in multiple myeloma
Miaomiao Sun, Wang Xiao-qian, Shou Yuwei, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
LncRNA TUG1 affects cell viability by regulating glycolysis in osteosarcoma cells
Xiufu Han, Yuan‐Han Yang, Yongjie Sun, et al.
Gene (2018) Vol. 674, pp. 87-92
Closed Access | Times Cited: 50
Irreversible Electroporation (IRE) in Locally Advanced Pancreatic Cancer: A Review of Current Clinical Outcomes, Mechanism of Action and Opportunities for Synergistic Therapy
Z Rai, Roger Feakins, Laura J. Pallett, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1609-1609
Open Access | Times Cited: 38
Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer
Lorenzo F. Sempere, Katherine Powell, Jatin Rana, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 3, pp. 761-776
Open Access | Times Cited: 35
Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
Aditi Jain, Vikas Bhardwaj
World Journal of Gastroenterology (2021) Vol. 27, Iss. 39, pp. 6527-6550
Open Access | Times Cited: 33
Effects of glycolysis on the polarization and function of tumor‑associated macrophages (Review)
Jiaying Cao, Feng Zeng, Shan Liao, et al.
International Journal of Oncology (2023) Vol. 62, Iss. 6
Open Access | Times Cited: 16
Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment
Xin Li, Jianbo Zhou, Xue Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Effects of CAF-Derived MicroRNA on Tumor Biology and Clinical Applications
Xu Wang, Xin Wang, Midie Xu, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3160-3160
Open Access | Times Cited: 28
Systematic Pan-Cancer Analysis Identifies CDK1 as an Immunological and Prognostic Biomarker
Yaqi Yang, Qin Liu, Xiyuan Guo, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 19
Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma
Mahrou Vahabi, Bilal Dehni, Inés Antomás, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 725-740
Open Access | Times Cited: 12
Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy
Han Zhang, Wenjin Xu, Haitao Zhu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 7, pp. 2003-2023
Open Access | Times Cited: 4
The Jun N-terminal kinases signaling pathway plays a “seesaw” role in ovarian carcinoma: a molecular aspect
Yingyu Dou, Xiao‐Yan Jiang, Hui Xie, et al.
Journal of Ovarian Research (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top